| Year |
Citation |
Score |
| 2021 |
Howe A, Bhatavdekar O, Salerno D, Josefsson A, Pacheco-Torres J, Bhujwalla ZM, Gabrielson KL, Sgouros G, Sofou S. Combination of carriers, with complementary intratumoral microdistributions of delivered α-particles, may realize the promise for Actinium-225 in large solid tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 34795012 DOI: 10.2967/jnumed.121.262992 |
0.536 |
|
| 2021 |
Prasad A, Nair R, Bhatavdekar O, Howe A, Salerno D, Sempkowski M, Josefsson A, Pacheco-Torres J, Bhujwalla ZM, Gabrielson KL, Sgouros G, Sofou S. Transport-driven engineering of liposomes for delivery of α-particle radiotherapy to solid tumors: effect on inhibition of tumor progression and onset delay of spontaneous metastases. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34117896 DOI: 10.1007/s00259-021-05406-z |
0.536 |
|
| 2019 |
Stras S, Howe A, Prasad A, Salerno D, Bhatavdekar O, Sofou S. Growth of Metastatic Triple-Negative Breast Cancer Is Inhibited by Deep Tumor-Penetrating and Slow Tumor-Clearing Chemotherapy: The Case of Tumor-Adhering Liposomes with Interstitial Drug Release. Molecular Pharmaceutics. PMID 31825626 DOI: 10.1021/acs.molpharmaceut.9b00812 |
0.318 |
|
| 2019 |
Howe AK, Sofou S. Mechanistic Studies on Daptomycin-Induced Phase-Transitions on Model Lipid Membranes: Effect on Membrane Permeability Biophysical Journal. 116: 85a. DOI: 10.1016/J.Bpj.2018.11.502 |
0.379 |
|
| 2019 |
Ganesh Prasad A, Salerno D, Howe AK, Mandar Bhatavdekar O, Sofou S. Location-Location-Location: Designing Cationic Charge Placement on Lipid Vesicles Determines their Interactions with Living Cells Biophysical Journal. 116: 296a. DOI: 10.1016/J.Bpj.2018.11.1602 |
0.333 |
|
| 2018 |
Kowzun MJ, Rifkin WJ, Borab ZM, Ellison T, Soares MA, Wilson SC, Lotfi P, Bandekar A, Sofou S, Saadeh PB, Ceradini DJ. Topical inhibition of PUMA signaling mitigates radiation injury. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. PMID 30155987 DOI: 10.1111/Wrr.12668 |
0.711 |
|
| 2018 |
McDevitt MR, Sgouros G, Sofou S. Targeted and Nontargeted α-Particle Therapies. Annual Review of Biomedical Engineering. PMID 29345977 DOI: 10.1146/Annurev-Bioeng-062117-120931 |
0.497 |
|
| 2017 |
Locke T, Sofou S. Clustered vs. uniform display of GALA-peptides on carrier nanoparticles: enhancing the permeation of non-charged fluid lipid-membranes. Langmuir : the Acs Journal of Surfaces and Colloids. PMID 29096061 DOI: 10.1021/Acs.Langmuir.7B03706 |
0.439 |
|
| 2017 |
Zhu C, Sempkowski M, Holleran T, Linz T, Bertalan T, Josefsson A, Bruchertseifer F, Morgenstern A, Sofou S. Alpha-particle radiotherapy: For large solid tumors diffusion trumps targeting. Biomaterials. 130: 67-75. PMID 28365545 DOI: 10.1016/J.Biomaterials.2017.03.035 |
0.42 |
|
| 2016 |
Stras S, Holleran T, Howe A, Sofou S. Interstitial Release of Cisplatin from Triggerable Liposomes Enhances Efficacy Against Triple Negative Breast Cancer Solid Tumor Analogues. Molecular Pharmaceutics. PMID 27482716 DOI: 10.1021/Acs.Molpharmaceut.6B00439 |
0.505 |
|
| 2016 |
Sempkowski M, Zhu C, Menzenski MZ, Kevrekidis IG, Bruchertseifer F, Morgenstern A, Sofou S. Sticky Patches on Lipid Nanoparticles Enable Selective Targeting and Killing of Untargetable Cancer Cells. Langmuir : the Acs Journal of Surfaces and Colloids. PMID 27468779 DOI: 10.1021/Acs.Langmuir.6B01464 |
0.43 |
|
| 2015 |
Zhu C, Bandekar A, Sempkowski M, Ray Banerjee S, Pomper MG, Bruchertseifer F, Morgenstern A, Sofou S. Nanoconjugation of PSMA-targeting ligands enhances perinuclear localization and improves efficacy of delivered alpha-particle emitters against tumor endothelial analogues. Molecular Cancer Therapeutics. PMID 26586724 DOI: 10.1158/1535-7163.Mct-15-0207 |
0.777 |
|
| 2015 |
Curtis EM, Xiao X, Sofou S, Hall CK. Phase separation behavior of mixed lipid systems at neutral and low pH: coarse-grained simulations with DMD/LIME. Langmuir : the Acs Journal of Surfaces and Colloids. 31: 1086-94. PMID 25549801 DOI: 10.1021/La504082X |
0.423 |
|
| 2015 |
Sempkowski M, Kevrekidis Y, Sofou S. Sticky Patches on Lipid Nanoparticles Generate Binding Geometries that Enable Effective Targeting of Otherwise Untargetable Cancers Biophysical Journal. 108: 345a. DOI: 10.1016/J.Bpj.2014.11.1889 |
0.475 |
|
| 2014 |
Sempkowski M, Locke T, Stras S, Zhu C, Sofou S. Liposome-based approaches for delivery of mainstream chemotherapeutics: preparation methods, liposome designs, therapeutic efficacy. Critical Reviews in Oncogenesis. 19: 177-221. PMID 25271431 DOI: 10.1615/Critrevoncog.2014011533 |
0.397 |
|
| 2014 |
Bandekar A, Zhu C, Jindal R, Bruchertseifer F, Morgenstern A, Sofou S. Anti-prostate-specific membrane antigen liposomes loaded with 225Ac for potential targeted antivascular α-particle therapy of cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 107-14. PMID 24337602 DOI: 10.2967/Jnumed.113.125476 |
0.759 |
|
| 2013 |
Bandekar A, Zhu C, Gomez A, Menzenski MZ, Sempkowski M, Sofou S. Masking and triggered unmasking of targeting ligands on liposomal chemotherapy selectively suppress tumor growth in vivo. Molecular Pharmaceutics. 10: 152-60. PMID 23134440 DOI: 10.1021/Mp3002717 |
0.822 |
|
| 2013 |
Bandekar A, Sofou S. Anti-PSMA liposomes loaded with actinium-225 for potential targeted antivascular alpha particle therapy of cancer Food, Pharmaceutical and Bioengineering Division 2013 - Core Programming Area At the 2013 Aiche Annual Meeting: Global Challenges For Engineering a Sustainable Future. 111. |
0.739 |
|
| 2012 |
Bandekar A, Karve S, Chang MY, Mu Q, Rotolo J, Sofou S. Antitumor efficacy following the intracellular and interstitial release of liposomal doxorubicin. Biomaterials. 33: 4345-52. PMID 22429980 DOI: 10.1016/J.Biomaterials.2012.02.039 |
0.81 |
|
| 2012 |
Bandekar A, Sofou S. Floret-shaped solid domains on giant fluid lipid vesicles induced by pH. Langmuir : the Acs Journal of Surfaces and Colloids. 28: 4113-22. PMID 22276950 DOI: 10.1021/La204765R |
0.766 |
|
| 2012 |
Bhagat M, Halligan S, Sofou S. Nanocarriers to solid tumors: considerations on tumor penetration and exposure of tumor cells to therapeutic agents. Current Pharmaceutical Biotechnology. 13: 1306-16. PMID 22201591 DOI: 10.2174/138920112800624256 |
0.762 |
|
| 2011 |
Mamasheva E, O'Donnell C, Bandekar A, Sofou S. Heterogeneous liposome membranes with pH-triggered permeability enhance the in vitro antitumor activity of folate-receptor targeted liposomal doxorubicin. Molecular Pharmaceutics. 8: 2224-32. PMID 21899300 DOI: 10.1021/Mp200079Y |
0.811 |
|
| 2010 |
Karve S, Bandekar A, Ali MR, Sofou S. The pH-dependent association with cancer cells of tunable functionalized lipid vesicles with encapsulated doxorubicin for high cell-kill selectivity. Biomaterials. 31: 4409-16. PMID 20189243 DOI: 10.1016/J.Biomaterials.2010.01.064 |
0.802 |
|
| 2010 |
Sofou S, Enmon R, Palm S, Kappel B, Zanzonico P, McDevitt MR, Scheinberg DA, Sgouros G. Large anti-HER2/neu liposomes for potential targeted intraperitoneal therapy of micrometastatic cancer. Journal of Liposome Research. 20: 330-40. PMID 20070139 DOI: 10.3109/08982100903544185 |
0.686 |
|
| 2010 |
Bhagat M, Sofou S. Membrane heterogeneities and fusogenicity in phosphatidylcholine-phosphatidic acid rigid vesicles as a function of pH and lipid chain mismatch. Langmuir : the Acs Journal of Surfaces and Colloids. 26: 1666-73. PMID 19813725 DOI: 10.1021/La9026283 |
0.779 |
|
| 2009 |
Karve S, Alaouie A, Zhou Y, Rotolo J, Sofou S. The use of pH-triggered leaky heterogeneities on rigid lipid bilayers to improve intracellular trafficking and therapeutic potential of targeted liposomal immunochemotherapy. Biomaterials. 30: 6055-64. PMID 19665223 DOI: 10.1016/J.Biomaterials.2009.07.038 |
0.754 |
|
| 2009 |
Kempegowda GB, Karve S, Bandekar A, Adhikari A, Khaimchayev T, Sofou S. pH-dependent formation of lipid heterogeneities controls surface topography and binding reactivity in functionalized bilayers. Langmuir : the Acs Journal of Surfaces and Colloids. 25: 8144-51. PMID 19594187 DOI: 10.1021/La9004032 |
0.788 |
|
| 2008 |
Sofou S. Radionuclide carriers for targeting of cancer. International Journal of Nanomedicine. 3: 181-99. PMID 18686778 DOI: 10.2147/Ijn.S2736 |
0.439 |
|
| 2008 |
Sofou S, Yu YB. Delivery systems for the targeted radiotherapy of cancer. Preface. Advanced Drug Delivery Reviews. 60: 1317-8. PMID 18538443 DOI: 10.1016/J.Addr.2008.04.004 |
0.381 |
|
| 2008 |
Chang MY, Seideman J, Sofou S. Enhanced loading efficiency and retention of 225Ac in rigid liposomes for potential targeted therapy of micrometastases. Bioconjugate Chemistry. 19: 1274-82. PMID 18505278 DOI: 10.1021/Bc700440A |
0.445 |
|
| 2008 |
Karve S, Bajagur Kempegowda G, Sofou S. Heterogeneous domains and membrane permeability in phosphatidylcholine-phosphatidic acid rigid vesicles as a function of pH and lipid chain mismatch. Langmuir : the Acs Journal of Surfaces and Colloids. 24: 5679-88. PMID 18471003 DOI: 10.1021/La800331A |
0.733 |
|
| 2008 |
Sofou S, Sgouros G. Antibody-targeted liposomes in cancer therapy and imaging. Expert Opinion On Drug Delivery. 5: 189-204. PMID 18248318 DOI: 10.1517/17425247.5.2.189 |
0.587 |
|
| 2008 |
Alaouie AM, Sofou S. Liposomes with triggered content release for cancer therapy Journal of Biomedical Nanotechnology. 4: 234-244. DOI: 10.1166/Jbn.2008.335 |
0.478 |
|
| 2008 |
Bhagat M, Sofou S. Fusion studies of charged heterogeneous membranes: Effect of pH and cholesterol Aiche Annual Meeting, Conference Proceedings. |
0.327 |
|
| 2008 |
Karve S, Gowda G, Sofou S. Heterogeneous domains and membrane permeability in phosphatidylcholine- phosphatidic acid rigid vesicles as a function of ph and lipid chain mismatch Aiche Annual Meeting, Conference Proceedings. |
0.662 |
|
| 2008 |
Karve S, Alaouie A, Sofou S. Anti-HER2/neu liposomes for triggered content release in ovarian and breast cancer cells Aiche Annual Meeting, Conference Proceedings. |
0.607 |
|
| 2008 |
Bandekar A, Karve S, Sofou S. pH-triggerable liposomes for delivery and release of doxorubicin Aiche Annual Meeting, Conference Proceedings. |
0.78 |
|
| 2007 |
Sofou S. Surface-active liposomes for targeted cancer therapy. Nanomedicine (London, England). 2: 711-24. PMID 17976032 DOI: 10.2217/17435889.2.5.711 |
0.437 |
|
| 2007 |
Sofou S, Kappel BJ, Jaggi JS, McDevitt MR, Scheinberg DA, Sgouros G. Enhanced retention of the α-particle-emitting daughters of actinium-225 by liposome carriers Bioconjugate Chemistry. 18: 2061-2067. PMID 17935286 DOI: 10.1021/Bc070075T |
0.614 |
|
| 2006 |
Karve S, Sofou S. Rigid-liposomes with engineered 'raft-switches' for controlled release of therapeutics Aiche Annual Meeting, Conference Proceedings. |
0.595 |
|
| 2005 |
Huang CC, Chang MY, Karve S, Sofou S. Engineered lipid-based 'polysomes' for targeted multimodal therapy of disseminated metastatic cancer Aiche Annual Meeting, Conference Proceedings. 8863. |
0.642 |
|
| 2004 |
Sofou S, Thomas JL, Lin HY, McDevitt MR, Scheinberg DA, Sgouros G. Engineered liposomes for potential alpha-particle therapy of metastatic cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 45: 253-60. PMID 14960644 |
0.631 |
|
| 2003 |
Sofou S, Thomas JL. Stable adhesion of phospholipid vesicles to modified gold surfaces. Biosensors & Bioelectronics. 18: 445-55. PMID 12604262 DOI: 10.1016/S0956-5663(02)00153-7 |
0.527 |
|
| 2003 |
Sofou S, Thomas JL. Effects of oxidation and reduction on the membrane activity of a cysteine dimerizable peptide Colloids and Surfaces B: Biointerfaces. 27: 197-207. DOI: 10.1016/S0927-7765(02)00068-1 |
0.367 |
|
| 2002 |
Sofou S, Thomas JL. Stable adsorption of lipid vesicles on modified gold surfaces Materials Research Society Symposium - Proceedings. 705: 171-176. DOI: 10.1557/Proc-705-Y6.3 |
0.339 |
|
| Show low-probability matches. |
